Germany
Japan
United Kingdom
China
Lenti ORF particles, PROL1 (mGFP-tagged) - Human proline rich, lacrimal 1 (PROL1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lentiviral Particles
DownloadUSD 820.00
3 Weeks
Lenti ORF particles, F9 (mGFP-tagged) - Human coagulation factor IX (F9), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, WNT11 (Myc-DDK tagged) - Human wingless-type MMTV integration site family, member 11 (WNT11), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, SLIT2 (Myc-DDK tagged) - Human slit homolog 2 (Drosophila) (SLIT2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TREM2 (mGFP-tagged) - Human triggering receptor expressed on myeloid cells 2 (TREM2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CRLF2 (Myc-DDK tagged) - Human cytokine receptor-like factor 2 (CRLF2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, IL37 (Myc-DDK-tagged)-Human interleukin 1 family, member 7 (zeta) (IL1F7), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
3 Weeks
Lenti ORF particles, ANGPTL4 (mGFP-tagged)-Human angiopoietin-like 4 (ANGPTL4), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
3 Weeks
Lenti ORF particles, IL36G (mGFP-tagged) - Human interleukin 1 family, member 9 (IL1F9), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
3 Weeks
Lenti ORF particles, SCG5 (mGFP-tagged) - Human secretogranin V (7B2 protein) (SCG5), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
3 Weeks
Lenti ORF particles, CSF3 (mGFP-tagged) - Human colony stimulating factor 3 (granulocyte) (CSF3), transcript variant 4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TEX264 (Myc-DDK tagged) - Human testis expressed 264 (TEX264), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TEX264 (mGFP-tagged) - Human testis expressed 264 (TEX264), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, DKK1 (Myc-DDK tagged) - Human dickkopf homolog 1 (Xenopus laevis) (DKK1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, DKK1 (mGFP-tagged) - Human dickkopf homolog 1 (Xenopus laevis) (DKK1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, COX16 (Myc-DDK tagged) - Human COX16 cytochrome c oxidase assembly homolog (S. cerevisiae) (COX16), nuclear gene encoding mitochondrial protein, transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, COX16 (mGFP-tagged) - Human COX16 cytochrome c oxidase assembly homolog (S. cerevisiae) (COX16), nuclear gene encoding mitochondrial protein, transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, EDEM2 (Myc-DDK tagged) - Human ER degradation enhancer, mannosidase alpha-like 2 (EDEM2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, EDEM2 (mGFP-tagged) - Human ER degradation enhancer, mannosidase alpha-like 2 (EDEM2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, KLK5 (Myc-DDK tagged) - Human kallikrein-related peptidase 5 (KLK5), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, KLK5 (mGFP-tagged) - Human kallikrein-related peptidase 5 (KLK5), transcript variant 3, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, DKK3 (Myc-DDK tagged) - Human dickkopf homolog 3 (Xenopus laevis) (DKK3), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, DKK3 (mGFP-tagged) - Human dickkopf homolog 3 (Xenopus laevis) (DKK3), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, NPC2 (Myc-DDK tagged) - Human Niemann-Pick disease, type C2 (NPC2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, NPC2 (mGFP-tagged) - Human Niemann-Pick disease, type C2 (NPC2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, ANGPTL7 (Myc-DDK tagged) - Human angiopoietin-like 7 (ANGPTL7), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, ANGPTL7 (mGFP-tagged) - Human angiopoietin-like 7 (ANGPTL7), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, RARRES2 (Myc-DDK tagged) - Human retinoic acid receptor responder (tazarotene induced) 2 (RARRES2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, RARRES2 (mGFP-tagged) - Human retinoic acid receptor responder (tazarotene induced) 2 (RARRES2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
2 Weeks
Lenti ORF particles, APOE (mGFP-tagged) - Human apolipoprotein E (APOE), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TGFBI (Myc-DDK tagged) - Human transforming growth factor, beta-induced, 68kDa (TGFBI), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, TGFBI (mGFP-tagged) - Human transforming growth factor, beta-induced, 68kDa (TGFBI), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CX3CL1 (Myc-DDK-tagged)-Human chemokine (C-X3-C motif) ligand 1 (CX3CL1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CX3CL1 (mGFP-tagged)-Human chemokine (C-X3-C motif) ligand 1 (CX3CL1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PGF (Myc-DDK tagged) - Human placental growth factor (PGF), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PGF (mGFP-tagged) - Human placental growth factor (PGF), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, CHGA (Myc-DDK tagged) - Human chromogranin A (parathyroid secretory protein 1) (CHGA), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, CHGA (mGFP-tagged) - Human chromogranin A (parathyroid secretory protein 1) (CHGA), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,344.00
5 Weeks
Lenti ORF particles, CFB (Myc-DDK tagged) - Human complement factor B (CFB), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,344.00
2 Weeks
Lenti ORF particles, CFB (mGFP-tagged) - Human complement factor B (CFB), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
5 Weeks
Lenti ORF particles, APOD (Myc-DDK tagged) - Human apolipoprotein D (APOD), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 1,020.00
2 Weeks
Lenti ORF particles, APOD (mGFP-tagged) - Human apolipoprotein D (APOD), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
5 Weeks
Lenti ORF particles, ADM (Myc-DDK tagged) - Human adrenomedullin (ADM), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
3 Weeks
Lenti ORF particles, ADM (mGFP-tagged) - Human adrenomedullin (ADM), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
11 Weeks
Lenti ORF particles, SERPINA3 (Myc-DDK-tagged)-Human serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 (SERPINA3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PCOLCE (Myc-DDK tagged) - Human procollagen C-endopeptidase enhancer (PCOLCE), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PCOLCE (mGFP-tagged) - Human procollagen C-endopeptidase enhancer (PCOLCE), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, STC2 (Myc-DDK tagged) - Human stanniocalcin 2 (STC2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
USD 820.00
6 Weeks
Lenti ORF particles, STC2 (mGFP-tagged) - Human stanniocalcin 2 (STC2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, CRTAP (Myc-DDK tagged) - Human cartilage associated protein (CRTAP), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Active filters
Mammalian Cell Selection
- Puromycin
Families
- Secreted Protein
Filter by
Target Symbol
- NRG1 (36)
- BDNF (32)
- VEGFA (32)
- DAG1 (26)
- SERPINA1 (22)
- ST3GAL3 (20)
- CSF2RA (18)
- FGFR2 (18)
- GSN (16)
- IL32 (16)
- PCSK6 (16)
- FCRLA (14)
- MUC1 (14)
- RNASE9 (14)
- SPAG11B (14)
- DCN (12)
- FGF1 (12)
- FGF13 (12)
- HYAL1 (12)
- IL1RAP (12)
- SIGLEC6 (12)
- TNFSF13 (12)
- CD164 (10)
- CD8B (10)
- CKLF (10)
- CRISP2 (10)
- EDA (10)
- FCGR3A (10)
- GDNF (10)
- GH1 (10)
- GHRL (10)
- GNAS (10)
- IL18BP (10)
- IL37 (10)
- MEPE (10)
- NELL2 (10)
- TCTN1 (10)
- VIT (10)
- ANXA2 (8)
- APOL1 (8)
- CHRDL1 (8)
- CSF1 (8)
- CSF3 (8)
- CSF3R (8)
- CSHL1 (8)
- CXCL12 (8)
- EDN3 (8)
- EGFR (8)
- FAM3A (8)
- FAS (8)
- FGF8 (8)
- FGL1 (8)
- FLT1 (8)
- FOLR1 (8)
- FOLR2 (8)
- GH2 (8)
- GP2 (8)
- HSD17B13 (8)
- IGF1 (8)
- IL1RN (8)
- IL24 (8)
- KLK11 (8)
- KLK3 (8)
- KLK8 (8)
- LEPR (8)
- LIPF (8)
- LRP8 (8)
- MFAP2 (8)
- POSTN (8)
- PRSS3 (8)
- PTHLH (8)
- RAB37 (8)
- RNASE1 (8)
- SHBG (8)
- TAC1 (8)
- TOR2A (8)
- VMO1 (8)
- ACE (6)
- ADAMDEC1 (6)
- ADAMTS13 (6)
- ADGRE5 (6)
- AMELX (6)
- ANGPT2 (6)
- ARTN (6)
- BMP4 (6)
- C14ORF93 (6)
- C1QTNF1 (6)
- C1QTNF7 (6)
- C2 (6)
- CALCA (6)
- CANT1 (6)
- CCL14 (6)
- CCL15 (6)
- CD8A (6)
- CLU (6)
- COL6A2 (6)
- CPA5 (6)
- CPZ (6)
- CSH2 (6)
- DKK3 (6)
Species
Lentivirus
Mutants
Pathways
- Cytokine-cytokine receptor interaction (495)
- Pathways in cancer (291)
- Jak-STAT signaling pathway (203)
- MAPK signaling pathway (186)
- Complement and coagulation cascades (136)
- Regulation of actin cytoskeleton (128)
- Metabolic pathways (116)
- Focal adhesion (109)
- Chemokine signaling pathway (106)
- Hematopoietic cell lineage (104)
- Melanoma (96)
- TGF-beta signaling pathway (80)
- ECM-receptor interaction (75)
- Neuroactive ligand-receptor interaction (68)
- Toll-like receptor signaling pathway (68)
- Hedgehog signaling pathway (66)
- Melanogenesis (62)
- Wnt signaling pathway (62)
- Pancreatic cancer (60)
- ErbB signaling pathway (58)
- Natural killer cell mediated cytotoxicity (58)
- Autoimmune thyroid disease (56)
- Basal cell carcinoma (56)
- GnRH signaling pathway (56)
- Bladder cancer (54)
- Dilated cardiomyopathy (54)
- Hypertrophic cardiomyopathy (HCM) (52)
- Prostate cancer (52)
- Renal cell carcinoma (52)
- Antigen processing and presentation (50)
- Systemic lupus erythematosus (50)
- VEGF signaling pathway (50)
- mTOR signaling pathway (50)
- Axon guidance (46)
- Endocytosis (46)
- RIG-I-like receptor signaling pathway (44)
- Neurotrophin signaling pathway (42)
- Cytosolic DNA-sensing pathway (40)
- Allograft rejection (38)
- Long-term depression (38)
- T cell receptor signaling pathway (36)
- Type I diabetes mellitus (36)
- Apoptosis (34)
- Viral myocarditis (34)
- Fc epsilon RI signaling pathway (32)
- Huntington's disease (32)
- PPAR signaling pathway (32)
- Fc gamma R-mediated phagocytosis (30)
- Prion diseases (30)
- Arachidonic acid metabolism (28)
- Primary immunodeficiency (28)
- Regulation of autophagy (28)
- Vascular smooth muscle contraction (28)
- p53 signaling pathway (28)
- Adipocytokine signaling pathway (26)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (26)
- Asthma (26)
- Cell adhesion molecules (CAMs) (26)
- NOD-like receptor signaling pathway (26)
- Ether lipid metabolism (24)
- Glycosphingolipid biosynthesis - lacto and neolacto series (24)
- Graft-versus-host disease (24)
- Keratan sulfate biosynthesis (24)
- Lysosome (24)
- Calcium signaling pathway (22)
- Gap junction (22)
- Glioma (20)
- Glycerophospholipid metabolism (20)
- Glycosaminoglycan degradation (20)
- Renin-angiotensin system (20)
- Small cell lung cancer (19)
- Alzheimer's disease (18)
- Glycerolipid metabolism (18)
- Linoleic acid metabolism (18)
- alpha-Linolenic acid metabolism (18)
- Colorectal cancer (16)
- Epithelial cell signaling in Helicobacter pylori infection (16)
- Non-small cell lung cancer (12)
- SNARE interactions in vesicular transport (12)
- Cell cycle (10)
- Glutathione metabolism (10)
- Oocyte meiosis (10)
- Progesterone-mediated oocyte maturation (10)
- Purine metabolism (10)
- Pyrimidine metabolism (10)
- Taste transduction (10)
- Vibrio cholerae infection (10)
- Adherens junction (8)
- Chronic myeloid leukemia (8)
- Dorso-ventral axis formation (8)
- Endometrial cancer (8)
- Leukocyte transendothelial migration (8)
- O-Glycan biosynthesis (8)
- Starch and sucrose metabolism (8)
- Type II diabetes mellitus (8)
- Amino sugar and nucleotide sugar metabolism (6)
- Amyotrophic lateral sclerosis (ALS) (6)
- N-Glycan biosynthesis (6)
- Glycosphingolipid biosynthesis - ganglio series (4)
- Glycosphingolipid biosynthesis - globo series (4)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (4)
- Histidine metabolism (4)
- Maturity onset diabetes of the young (4)
- Other glycan degradation (4)
- Pathogenic Escherichia coli infection (4)
- Acute myeloid leukemia (2)
- Arginine and proline metabolism (2)
- Biotin metabolism (2)
- Folate biosynthesis (2)
- Galactose metabolism (2)
- Insulin signaling pathway (2)
- Nitrogen metabolism (2)
- Proteasome (2)
- Riboflavin metabolism (2)
- Tryptophan metabolism (2)
- Tyrosine metabolism (2)
- beta-Alanine metabolism (2)